Apheresis Market By Product (Devices, Disposable and Reagents, Software), By Method (Centrifugation, Membrane Separation, Selective Adsorption), By Procedure (Donor/Automated Apheresis, Therapeutic Apheresis), By Component (Plasma (Plasmapheresis), Platel
Description
Apheresis Market By Product (Devices, Disposable and Reagents, Software), By Method (Centrifugation, Membrane Separation, Selective Adsorption), By Procedure (Donor/Automated Apheresis, Therapeutic Apheresis), By Component (Plasma (Plasmapheresis), Platelets (Plateletpheresis), Leukocytes (Leukapheresis or leukopheresis), Lymphocytes (Lymphopheresis or lymphapheresis), RBC's (Erythropheresis)), By End User (Blood Centers, Hospitals, Other End Users): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global Apheresis market was valued at $ 2383.41 million in 2021, and is projected to reach $ 5300.57 million by 2031, registering a CAGR of 8.3% from 2022 to 2031.
Apheresis procedures involve separation of desired components from the blood, while the remaining is either returned to the donor or the patient. For a donor, apheresis may be used to collect a particular blood component such as platelets or plasma. For a patient apheresis may be used to remove a disease provoking component of blood. After removing a blood component, the remaining blood components are then returned into the bloodstream of the patient or donor.
Use of large-scale plasma donations in the treatment of trauma patients, burn victims, and patients suffering from serious illness or injuries primarily contributes toward the growth of the apheresis market. In addition, rise in prevalence of cancer and surge in number of patients undergoing surgery have increased the number of plateletpheresis across the globe, thereby supplementing the market growth. However, dearth of skilled professionals and post-procedural complications associated with apheresis are anticipated to hamper the market growth. On the contrary, advancements in the healthcare sector in emerging economies are expected to offer significant profitable opportunities for the market players.
Apheresis market is segmented into product, method, procedure, component, end user, and region. On the basis of product, the market is classified into devices, disposable & reagents, and software. By method, it is categorized into centrifugation, membrane separation, and selective adsorption. Depending on procedure, it is divided into donor/automated apheresis and therapeutic apheresis. According to component, it is fragmented into plasma (plasmapheresis), platelets (plateletpheresis), leukocytes (leukapheresis), lymphocytes (lymph apheresis), and RBCS (erythropheresis). By end user, it is segmented into blood centers, hospitals, and others include academic institutions, research institutes (blood institutes), and biopharmaceutical manufacturers.
By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in this report include Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Fresenius Kabi, Haemonetics Corporation, Charles River Laboratories International, Inc, Kaneka Corporation, Kawasumi Laboratories Inc, Nikkiso Co. Ltd, Terumo BCT.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the apheresis market analysis from 2022 to 2031 to identify the prevailing apheresis market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the apheresis market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global apheresis market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
Devices
Disposable and Reagents
Software
By Method
Centrifugation
Membrane Separation
Selective Adsorption
By Procedure
Donor/Automated Apheresis
Therapeutic Apheresis
By Component
Plasma (Plasmapheresis)
Platelets (Plateletpheresis)
Leukocytes (Leukapheresis or leukopheresis)
Lymphocytes (Lymphopheresis or lymphapheresis)
RBC's (Erythropheresis)
By End User
Blood Centers
Hospitals
Other End Users
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Haemonetics Corporation
Fresenius Kabi
Terumo BCT, Inc
Asahi Kasei Medical Co., Ltd
Kaneka Corporation
Kawasumi Laboratories Inc
Cerus Corporation
B. Braun Melsungen AG
Nikkiso Co., Ltd
Charles River Laboratories International, Inc.
The global Apheresis market was valued at $ 2383.41 million in 2021, and is projected to reach $ 5300.57 million by 2031, registering a CAGR of 8.3% from 2022 to 2031.
Apheresis procedures involve separation of desired components from the blood, while the remaining is either returned to the donor or the patient. For a donor, apheresis may be used to collect a particular blood component such as platelets or plasma. For a patient apheresis may be used to remove a disease provoking component of blood. After removing a blood component, the remaining blood components are then returned into the bloodstream of the patient or donor.
Use of large-scale plasma donations in the treatment of trauma patients, burn victims, and patients suffering from serious illness or injuries primarily contributes toward the growth of the apheresis market. In addition, rise in prevalence of cancer and surge in number of patients undergoing surgery have increased the number of plateletpheresis across the globe, thereby supplementing the market growth. However, dearth of skilled professionals and post-procedural complications associated with apheresis are anticipated to hamper the market growth. On the contrary, advancements in the healthcare sector in emerging economies are expected to offer significant profitable opportunities for the market players.
Apheresis market is segmented into product, method, procedure, component, end user, and region. On the basis of product, the market is classified into devices, disposable & reagents, and software. By method, it is categorized into centrifugation, membrane separation, and selective adsorption. Depending on procedure, it is divided into donor/automated apheresis and therapeutic apheresis. According to component, it is fragmented into plasma (plasmapheresis), platelets (plateletpheresis), leukocytes (leukapheresis), lymphocytes (lymph apheresis), and RBCS (erythropheresis). By end user, it is segmented into blood centers, hospitals, and others include academic institutions, research institutes (blood institutes), and biopharmaceutical manufacturers.
By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in this report include Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Fresenius Kabi, Haemonetics Corporation, Charles River Laboratories International, Inc, Kaneka Corporation, Kawasumi Laboratories Inc, Nikkiso Co. Ltd, Terumo BCT.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the apheresis market analysis from 2022 to 2031 to identify the prevailing apheresis market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the apheresis market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global apheresis market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
Devices
Disposable and Reagents
Software
By Method
Centrifugation
Membrane Separation
Selective Adsorption
By Procedure
Donor/Automated Apheresis
Therapeutic Apheresis
By Component
Plasma (Plasmapheresis)
Platelets (Plateletpheresis)
Leukocytes (Leukapheresis or leukopheresis)
Lymphocytes (Lymphopheresis or lymphapheresis)
RBC's (Erythropheresis)
By End User
Blood Centers
Hospitals
Other End Users
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Haemonetics Corporation
Fresenius Kabi
Terumo BCT, Inc
Asahi Kasei Medical Co., Ltd
Kaneka Corporation
Kawasumi Laboratories Inc
Cerus Corporation
B. Braun Melsungen AG
Nikkiso Co., Ltd
Charles River Laboratories International, Inc.
Table of Contents
270 Pages
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: APHERESIS MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Devices
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Disposable and Reagents
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Software
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- CHAPTER 5: APHERESIS MARKET, BY METHOD
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Centrifugation
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Membrane Separation
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Selective Adsorption
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: APHERESIS MARKET, BY PROCEDURE
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Donor/Automated Apheresis
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Therapeutic Apheresis
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- CHAPTER 7: APHERESIS MARKET, BY COMPONENT
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 Plasma (Plasmapheresis)
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
- 7.3 Platelets (Plateletpheresis)
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
- 7.4 Leukocytes (Leukapheresis or leukopheresis)
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country
- 7.5 Lymphocytes (Lymphopheresis or lymphapheresis)
- 7.5.1 Key market trends, growth factors and opportunities
- 7.5.2 Market size and forecast, by region
- 7.5.3 Market analysis by country
- 7.6 RBC's (Erythropheresis)
- 7.6.1 Key market trends, growth factors and opportunities
- 7.6.2 Market size and forecast, by region
- 7.6.3 Market analysis by country
- CHAPTER 8: APHERESIS MARKET, BY END USER
- 8.1 Overview
- 8.1.1 Market size and forecast
- 8.2 Blood Centers
- 8.2.1 Key market trends, growth factors and opportunities
- 8.2.2 Market size and forecast, by region
- 8.2.3 Market analysis by country
- 8.3 Hospitals
- 8.3.1 Key market trends, growth factors and opportunities
- 8.3.2 Market size and forecast, by region
- 8.3.3 Market analysis by country
- 8.4 Other End Users
- 8.4.1 Key market trends, growth factors and opportunities
- 8.4.2 Market size and forecast, by region
- 8.4.3 Market analysis by country
- CHAPTER 9: APHERESIS MARKET, BY REGION
- 9.1 Overview
- 9.1.1 Market size and forecast
- 9.2 North America
- 9.2.1 Key trends and opportunities
- 9.2.2 North America Market size and forecast, by Product
- 9.2.3 North America Market size and forecast, by Method
- 9.2.4 North America Market size and forecast, by Procedure
- 9.2.5 North America Market size and forecast, by Component
- 9.2.6 North America Market size and forecast, by End User
- 9.2.7 North America Market size and forecast, by country
- 9.2.7.1 U.S.
- 9.2.7.1.1 Market size and forecast, by Product
- 9.2.7.1.2 Market size and forecast, by Method
- 9.2.7.1.3 Market size and forecast, by Procedure
- 9.2.7.1.4 Market size and forecast, by Component
- 9.2.7.1.5 Market size and forecast, by End User
- 9.2.7.2 Canada
- 9.2.7.2.1 Market size and forecast, by Product
- 9.2.7.2.2 Market size and forecast, by Method
- 9.2.7.2.3 Market size and forecast, by Procedure
- 9.2.7.2.4 Market size and forecast, by Component
- 9.2.7.2.5 Market size and forecast, by End User
- 9.2.7.3 Mexico
- 9.2.7.3.1 Market size and forecast, by Product
- 9.2.7.3.2 Market size and forecast, by Method
- 9.2.7.3.3 Market size and forecast, by Procedure
- 9.2.7.3.4 Market size and forecast, by Component
- 9.2.7.3.5 Market size and forecast, by End User
- 9.3 Europe
- 9.3.1 Key trends and opportunities
- 9.3.2 Europe Market size and forecast, by Product
- 9.3.3 Europe Market size and forecast, by Method
- 9.3.4 Europe Market size and forecast, by Procedure
- 9.3.5 Europe Market size and forecast, by Component
- 9.3.6 Europe Market size and forecast, by End User
- 9.3.7 Europe Market size and forecast, by country
- 9.3.7.1 Germany
- 9.3.7.1.1 Market size and forecast, by Product
- 9.3.7.1.2 Market size and forecast, by Method
- 9.3.7.1.3 Market size and forecast, by Procedure
- 9.3.7.1.4 Market size and forecast, by Component
- 9.3.7.1.5 Market size and forecast, by End User
- 9.3.7.2 France
- 9.3.7.2.1 Market size and forecast, by Product
- 9.3.7.2.2 Market size and forecast, by Method
- 9.3.7.2.3 Market size and forecast, by Procedure
- 9.3.7.2.4 Market size and forecast, by Component
- 9.3.7.2.5 Market size and forecast, by End User
- 9.3.7.3 U.K.
- 9.3.7.3.1 Market size and forecast, by Product
- 9.3.7.3.2 Market size and forecast, by Method
- 9.3.7.3.3 Market size and forecast, by Procedure
- 9.3.7.3.4 Market size and forecast, by Component
- 9.3.7.3.5 Market size and forecast, by End User
- 9.3.7.4 Italy
- 9.3.7.4.1 Market size and forecast, by Product
- 9.3.7.4.2 Market size and forecast, by Method
- 9.3.7.4.3 Market size and forecast, by Procedure
- 9.3.7.4.4 Market size and forecast, by Component
- 9.3.7.4.5 Market size and forecast, by End User
- 9.3.7.5 Spain
- 9.3.7.5.1 Market size and forecast, by Product
- 9.3.7.5.2 Market size and forecast, by Method
- 9.3.7.5.3 Market size and forecast, by Procedure
- 9.3.7.5.4 Market size and forecast, by Component
- 9.3.7.5.5 Market size and forecast, by End User
- 9.3.7.6 Rest of Europe
- 9.3.7.6.1 Market size and forecast, by Product
- 9.3.7.6.2 Market size and forecast, by Method
- 9.3.7.6.3 Market size and forecast, by Procedure
- 9.3.7.6.4 Market size and forecast, by Component
- 9.3.7.6.5 Market size and forecast, by End User
- 9.4 Asia-Pacific
- 9.4.1 Key trends and opportunities
- 9.4.2 Asia-Pacific Market size and forecast, by Product
- 9.4.3 Asia-Pacific Market size and forecast, by Method
- 9.4.4 Asia-Pacific Market size and forecast, by Procedure
- 9.4.5 Asia-Pacific Market size and forecast, by Component
- 9.4.6 Asia-Pacific Market size and forecast, by End User
- 9.4.7 Asia-Pacific Market size and forecast, by country
- 9.4.7.1 Japan
- 9.4.7.1.1 Market size and forecast, by Product
- 9.4.7.1.2 Market size and forecast, by Method
- 9.4.7.1.3 Market size and forecast, by Procedure
- 9.4.7.1.4 Market size and forecast, by Component
- 9.4.7.1.5 Market size and forecast, by End User
- 9.4.7.2 China
- 9.4.7.2.1 Market size and forecast, by Product
- 9.4.7.2.2 Market size and forecast, by Method
- 9.4.7.2.3 Market size and forecast, by Procedure
- 9.4.7.2.4 Market size and forecast, by Component
- 9.4.7.2.5 Market size and forecast, by End User
- 9.4.7.3 India
- 9.4.7.3.1 Market size and forecast, by Product
- 9.4.7.3.2 Market size and forecast, by Method
- 9.4.7.3.3 Market size and forecast, by Procedure
- 9.4.7.3.4 Market size and forecast, by Component
- 9.4.7.3.5 Market size and forecast, by End User
- 9.4.7.4 Australia
- 9.4.7.4.1 Market size and forecast, by Product
- 9.4.7.4.2 Market size and forecast, by Method
- 9.4.7.4.3 Market size and forecast, by Procedure
- 9.4.7.4.4 Market size and forecast, by Component
- 9.4.7.4.5 Market size and forecast, by End User
- 9.4.7.5 South Korea
- 9.4.7.5.1 Market size and forecast, by Product
- 9.4.7.5.2 Market size and forecast, by Method
- 9.4.7.5.3 Market size and forecast, by Procedure
- 9.4.7.5.4 Market size and forecast, by Component
- 9.4.7.5.5 Market size and forecast, by End User
- 9.4.7.6 Rest of Asia-Pacific
- 9.4.7.6.1 Market size and forecast, by Product
- 9.4.7.6.2 Market size and forecast, by Method
- 9.4.7.6.3 Market size and forecast, by Procedure
- 9.4.7.6.4 Market size and forecast, by Component
- 9.4.7.6.5 Market size and forecast, by End User
- 9.5 LAMEA
- 9.5.1 Key trends and opportunities
- 9.5.2 LAMEA Market size and forecast, by Product
- 9.5.3 LAMEA Market size and forecast, by Method
- 9.5.4 LAMEA Market size and forecast, by Procedure
- 9.5.5 LAMEA Market size and forecast, by Component
- 9.5.6 LAMEA Market size and forecast, by End User
- 9.5.7 LAMEA Market size and forecast, by country
- 9.5.7.1 Brazil
- 9.5.7.1.1 Market size and forecast, by Product
- 9.5.7.1.2 Market size and forecast, by Method
- 9.5.7.1.3 Market size and forecast, by Procedure
- 9.5.7.1.4 Market size and forecast, by Component
- 9.5.7.1.5 Market size and forecast, by End User
- 9.5.7.2 Saudi Arabia
- 9.5.7.2.1 Market size and forecast, by Product
- 9.5.7.2.2 Market size and forecast, by Method
- 9.5.7.2.3 Market size and forecast, by Procedure
- 9.5.7.2.4 Market size and forecast, by Component
- 9.5.7.2.5 Market size and forecast, by End User
- 9.5.7.3 South Africa
- 9.5.7.3.1 Market size and forecast, by Product
- 9.5.7.3.2 Market size and forecast, by Method
- 9.5.7.3.3 Market size and forecast, by Procedure
- 9.5.7.3.4 Market size and forecast, by Component
- 9.5.7.3.5 Market size and forecast, by End User
- 9.5.7.4 Rest of LAMEA
- 9.5.7.4.1 Market size and forecast, by Product
- 9.5.7.4.2 Market size and forecast, by Method
- 9.5.7.4.3 Market size and forecast, by Procedure
- 9.5.7.4.4 Market size and forecast, by Component
- 9.5.7.4.5 Market size and forecast, by End User
- CHAPTER 10: COMPANY LANDSCAPE
- 10.1. Introduction
- 10.2. Top winning strategies
- 10.3. Product Mapping of Top 10 Player
- 10.4. Competitive Dashboard
- 10.5. Competitive Heatmap
- 10.6. Key developments
- CHAPTER 11: COMPANY PROFILES
- 11.1 Haemonetics Corporation
- 11.1.1 Company overview
- 11.1.2 Company snapshot
- 11.1.3 Operating business segments
- 11.1.4 Product portfolio
- 11.1.5 Business performance
- 11.1.6 Key strategic moves and developments
- 11.2 Fresenius Kabi
- 11.2.1 Company overview
- 11.2.2 Company snapshot
- 11.2.3 Operating business segments
- 11.2.4 Product portfolio
- 11.2.5 Business performance
- 11.2.6 Key strategic moves and developments
- 11.3 Terumo BCT, Inc
- 11.3.1 Company overview
- 11.3.2 Company snapshot
- 11.3.3 Operating business segments
- 11.3.4 Product portfolio
- 11.3.5 Business performance
- 11.3.6 Key strategic moves and developments
- 11.4 Asahi Kasei Medical Co., Ltd
- 11.4.1 Company overview
- 11.4.2 Company snapshot
- 11.4.3 Operating business segments
- 11.4.4 Product portfolio
- 11.4.5 Business performance
- 11.4.6 Key strategic moves and developments
- 11.5 Kaneka Corporation
- 11.5.1 Company overview
- 11.5.2 Company snapshot
- 11.5.3 Operating business segments
- 11.5.4 Product portfolio
- 11.5.5 Business performance
- 11.5.6 Key strategic moves and developments
- 11.6 Kawasumi Laboratories Inc
- 11.6.1 Company overview
- 11.6.2 Company snapshot
- 11.6.3 Operating business segments
- 11.6.4 Product portfolio
- 11.6.5 Business performance
- 11.6.6 Key strategic moves and developments
- 11.7 Cerus Corporation
- 11.7.1 Company overview
- 11.7.2 Company snapshot
- 11.7.3 Operating business segments
- 11.7.4 Product portfolio
- 11.7.5 Business performance
- 11.7.6 Key strategic moves and developments
- 11.8 B. Braun Melsungen AG
- 11.8.1 Company overview
- 11.8.2 Company snapshot
- 11.8.3 Operating business segments
- 11.8.4 Product portfolio
- 11.8.5 Business performance
- 11.8.6 Key strategic moves and developments
- 11.9 Nikkiso Co., Ltd
- 11.9.1 Company overview
- 11.9.2 Company snapshot
- 11.9.3 Operating business segments
- 11.9.4 Product portfolio
- 11.9.5 Business performance
- 11.9.6 Key strategic moves and developments
- 11.10 Charles River Laboratories International, Inc.
- 11.10.1 Company overview
- 11.10.2 Company snapshot
- 11.10.3 Operating business segments
- 11.10.4 Product portfolio
- 11.10.5 Business performance
- 11.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 2. APHERESIS MARKET SIZE, FOR DEVICES, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. APHERESIS MARKET FOR DEVICES BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. APHERESIS MARKET SIZE, FOR DISPOSABLE AND REAGENTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. APHERESIS MARKET FOR DISPOSABLE AND REAGENTS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. APHERESIS MARKET SIZE, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
- TABLE 7. APHERESIS MARKET FOR SOFTWARE BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 8. GLOBAL APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 9. APHERESIS MARKET SIZE, FOR CENTRIFUGATION, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. APHERESIS MARKET FOR CENTRIFUGATION BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 11. APHERESIS MARKET SIZE, FOR MEMBRANE SEPARATION, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. APHERESIS MARKET FOR MEMBRANE SEPARATION BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 13. APHERESIS MARKET SIZE, FOR SELECTIVE ADSORPTION, BY REGION, 2021-2031 ($MILLION)
- TABLE 14. APHERESIS MARKET FOR SELECTIVE ADSORPTION BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 15. GLOBAL APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 16. APHERESIS MARKET SIZE, FOR DONOR/AUTOMATED APHERESIS, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. APHERESIS MARKET FOR DONOR/AUTOMATED APHERESIS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 18. APHERESIS MARKET SIZE, FOR THERAPEUTIC APHERESIS, BY REGION, 2021-2031 ($MILLION)
- TABLE 19. APHERESIS MARKET FOR THERAPEUTIC APHERESIS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 20. GLOBAL APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 21. APHERESIS MARKET SIZE, FOR PLASMA (PLASMAPHERESIS), BY REGION, 2021-2031 ($MILLION)
- TABLE 22. APHERESIS MARKET FOR PLASMA (PLASMAPHERESIS) BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 23. APHERESIS MARKET SIZE, FOR PLATELETS (PLATELETPHERESIS), BY REGION, 2021-2031 ($MILLION)
- TABLE 24. APHERESIS MARKET FOR PLATELETS (PLATELETPHERESIS) BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 25. APHERESIS MARKET SIZE, FOR LEUKOCYTES (LEUKAPHERESIS OR LEUKOPHERESIS), BY REGION, 2021-2031 ($MILLION)
- TABLE 26. APHERESIS MARKET FOR LEUKOCYTES (LEUKAPHERESIS OR LEUKOPHERESIS) BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 27. APHERESIS MARKET SIZE, FOR LYMPHOCYTES (LYMPHOPHERESIS OR LYMPHAPHERESIS), BY REGION, 2021-2031 ($MILLION)
- TABLE 28. APHERESIS MARKET FOR LYMPHOCYTES (LYMPHOPHERESIS OR LYMPHAPHERESIS) BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 29. APHERESIS MARKET SIZE, FOR RBC'S (ERYTHROPHERESIS), BY REGION, 2021-2031 ($MILLION)
- TABLE 30. APHERESIS MARKET FOR RBC'S (ERYTHROPHERESIS) BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 31. GLOBAL APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 32. APHERESIS MARKET SIZE, FOR BLOOD CENTERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 33. APHERESIS MARKET FOR BLOOD CENTERS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 34. APHERESIS MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
- TABLE 35. APHERESIS MARKET FOR HOSPITALS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 36. APHERESIS MARKET SIZE, FOR OTHER END USERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 37. APHERESIS MARKET FOR OTHER END USERS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 38. APHERESIS MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 39. NORTH AMERICA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 40. NORTH AMERICA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 41. NORTH AMERICA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 42. NORTH AMERICA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 43. NORTH AMERICA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 44. NORTH AMERICA APHERESIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 45. U.S. APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 46. U.S. APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 47. U.S. APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 48. U.S. APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 49. U.S. APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 50. CANADA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 51. CANADA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 52. CANADA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 53. CANADA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 54. CANADA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 55. MEXICO APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 56. MEXICO APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 57. MEXICO APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 58. MEXICO APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 59. MEXICO APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 60. EUROPE APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 61. EUROPE APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 62. EUROPE APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 63. EUROPE APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 64. EUROPE APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 65. EUROPE APHERESIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 66. GERMANY APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 67. GERMANY APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 68. GERMANY APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 69. GERMANY APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 70. GERMANY APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 71. FRANCE APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 72. FRANCE APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 73. FRANCE APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 74. FRANCE APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 75. FRANCE APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 76. U.K. APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 77. U.K. APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 78. U.K. APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 79. U.K. APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 80. U.K. APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 81. ITALY APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 82. ITALY APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 83. ITALY APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 84. ITALY APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 85. ITALY APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 86. SPAIN APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 87. SPAIN APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 88. SPAIN APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 89. SPAIN APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 90. SPAIN APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 91. REST OF EUROPE APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 92. REST OF EUROPE APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 93. REST OF EUROPE APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 94. REST OF EUROPE APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 95. REST OF EUROPE APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 96. ASIA-PACIFIC APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 97. ASIA-PACIFIC APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 98. ASIA-PACIFIC APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 99. ASIA-PACIFIC APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 100. ASIA-PACIFIC APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 101. ASIA-PACIFIC APHERESIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 102. JAPAN APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 103. JAPAN APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 104. JAPAN APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 105. JAPAN APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 106. JAPAN APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 107. CHINA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 108. CHINA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 109. CHINA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 110. CHINA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 111. CHINA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 112. INDIA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 113. INDIA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 114. INDIA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 115. INDIA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 116. INDIA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 117. AUSTRALIA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 118. AUSTRALIA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 119. AUSTRALIA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 120. AUSTRALIA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 121. AUSTRALIA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 122. SOUTH KOREA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 123. SOUTH KOREA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 124. SOUTH KOREA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 125. SOUTH KOREA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 126. SOUTH KOREA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 127. REST OF ASIA-PACIFIC APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 128. REST OF ASIA-PACIFIC APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 129. REST OF ASIA-PACIFIC APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 130. REST OF ASIA-PACIFIC APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 131. REST OF ASIA-PACIFIC APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 132. LAMEA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 133. LAMEA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 134. LAMEA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 135. LAMEA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 136. LAMEA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 137. LAMEA APHERESIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 138. BRAZIL APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 139. BRAZIL APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 140. BRAZIL APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 141. BRAZIL APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 142. BRAZIL APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 143. SAUDI ARABIA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 144. SAUDI ARABIA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 145. SAUDI ARABIA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 146. SAUDI ARABIA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 147. SAUDI ARABIA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 148. SOUTH AFRICA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 149. SOUTH AFRICA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 150. SOUTH AFRICA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 151. SOUTH AFRICA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 152. SOUTH AFRICA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 153. REST OF LAMEA APHERESIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 154. REST OF LAMEA APHERESIS MARKET, BY METHOD, 2021-2031 ($MILLION)
- TABLE 155. REST OF LAMEA APHERESIS MARKET, BY PROCEDURE, 2021-2031 ($MILLION)
- TABLE 156. REST OF LAMEA APHERESIS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
- TABLE 157. REST OF LAMEA APHERESIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 158.HAEMONETICS CORPORATION: COMPANY SNAPSHOT
- TABLE 159.HAEMONETICS CORPORATION: OPERATING SEGMENTS
- TABLE 160.HAEMONETICS CORPORATION: PRODUCT PORTFOLIO
- TABLE 161.HAEMONETICS CORPORATION: NET SALES,
- TABLE 162.HAEMONETICS CORPORATION: KEY STRATERGIES
- TABLE 163.FRESENIUS KABI: COMPANY SNAPSHOT
- TABLE 164.FRESENIUS KABI: OPERATING SEGMENTS
- TABLE 165.FRESENIUS KABI: PRODUCT PORTFOLIO
- TABLE 166.FRESENIUS KABI: NET SALES,
- TABLE 167.FRESENIUS KABI: KEY STRATERGIES
- TABLE 168.TERUMO BCT, INC: COMPANY SNAPSHOT
- TABLE 169.TERUMO BCT, INC: OPERATING SEGMENTS
- TABLE 170.TERUMO BCT, INC: PRODUCT PORTFOLIO
- TABLE 171.TERUMO BCT, INC: NET SALES,
- TABLE 172.TERUMO BCT, INC: KEY STRATERGIES
- TABLE 173.ASAHI KASEI MEDICAL CO., LTD: COMPANY SNAPSHOT
- TABLE 174.ASAHI KASEI MEDICAL CO., LTD: OPERATING SEGMENTS
- TABLE 175.ASAHI KASEI MEDICAL CO., LTD: PRODUCT PORTFOLIO
- TABLE 176.ASAHI KASEI MEDICAL CO., LTD: NET SALES,
- TABLE 177.ASAHI KASEI MEDICAL CO., LTD: KEY STRATERGIES
- TABLE 178.KANEKA CORPORATION: COMPANY SNAPSHOT
- TABLE 179.KANEKA CORPORATION: OPERATING SEGMENTS
- TABLE 180.KANEKA CORPORATION: PRODUCT PORTFOLIO
- TABLE 181.KANEKA CORPORATION: NET SALES,
- TABLE 182.KANEKA CORPORATION: KEY STRATERGIES
- TABLE 183.KAWASUMI LABORATORIES INC: COMPANY SNAPSHOT
- TABLE 184.KAWASUMI LABORATORIES INC: OPERATING SEGMENTS
- TABLE 185.KAWASUMI LABORATORIES INC: PRODUCT PORTFOLIO
- TABLE 186.KAWASUMI LABORATORIES INC: NET SALES,
- TABLE 187.KAWASUMI LABORATORIES INC: KEY STRATERGIES
- TABLE 188.CERUS CORPORATION: COMPANY SNAPSHOT
- TABLE 189.CERUS CORPORATION: OPERATING SEGMENTS
- TABLE 190.CERUS CORPORATION: PRODUCT PORTFOLIO
- TABLE 191.CERUS CORPORATION: NET SALES,
- TABLE 192.CERUS CORPORATION: KEY STRATERGIES
- TABLE 193.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
- TABLE 194.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
- TABLE 195.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
- TABLE 196.B. BRAUN MELSUNGEN AG: NET SALES,
- TABLE 197.B. BRAUN MELSUNGEN AG: KEY STRATERGIES
- TABLE 198.NIKKISO CO., LTD: COMPANY SNAPSHOT
- TABLE 199.NIKKISO CO., LTD: OPERATING SEGMENTS
- TABLE 200.NIKKISO CO., LTD: PRODUCT PORTFOLIO
- TABLE 201.NIKKISO CO., LTD: NET SALES,
- TABLE 202.NIKKISO CO., LTD: KEY STRATERGIES
- TABLE 203.CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT
- TABLE 204.CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: OPERATING SEGMENTS
- TABLE 205.CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCT PORTFOLIO
- TABLE 206.CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: NET SALES,
- TABLE 207.CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.APHERESIS MARKET SEGMENTATION
- FIGURE 2.APHERESIS MARKET,2021-2031
- FIGURE 3.APHERESIS MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.APHERESIS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.APHERESIS MARKET,BY PRODUCT,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DEVICES APHERESIS MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DISPOSABLE AND REAGENTS APHERESIS MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF SOFTWARE APHERESIS MARKET,2021-2031(%)
- FIGURE 16.APHERESIS MARKET,BY METHOD,2021(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CENTRIFUGATION APHERESIS MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF MEMBRANE SEPARATION APHERESIS MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF SELECTIVE ADSORPTION APHERESIS MARKET,2021-2031(%)
- FIGURE 20.APHERESIS MARKET,BY PROCEDURE,2021(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DONOR/AUTOMATED APHERESIS APHERESIS MARKET,2021-2031(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF THERAPEUTIC APHERESIS APHERESIS MARKET,2021-2031(%)
- FIGURE 23.APHERESIS MARKET,BY COMPONENT,2021(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF PLASMA (PLASMAPHERESIS) APHERESIS MARKET,2021-2031(%)
- FIGURE 25.COMPARATIVE SHARE ANALYSIS OF PLATELETS (PLATELETPHERESIS) APHERESIS MARKET,2021-2031(%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
